Liheng Guo

Prof. Dr. Liheng Guo


Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 October 2016 in BMC Cardiovascular Disorders
Verified
Journal Article
Open access
PDF file
TZTian Zuo
Tian Zuo
XLXuehui Liu
Xuehui Liu
LJLu Jiang
Lu Jiang
SMShuai Mao
Shuai Mao
XYXin Yin
Xin Yin
LGLiheng Guo
Liheng Guo
Hyperuricemia may be associated with an increased risk of coronary heart disease (CHD) mortality; however, the results from prospective studies are conflicting. The objective of this study was to assess the association between hyperuricemia and risk of CHD mortality by performing a meta-analysis. Pubmed and Embase were searched for relevant prospective cohort studies published until July 2015. Studies were included only if they reported data on CHD mortality related to hyperuricemia in a general population. The pooled adjusted relative risk (RR) was calculated using a random-effects model. A total of 14 studies involving 341 389 adults were identified. Hyperuricemia was associated with an increased risk of CHD mortality (RR: 1.14; 95 % CI: 1.06–1.23) and all-cause mortality (RR: 1.20; 95 % CI: 1.13–1.28). For each increase of 1 mg/dl of serum uric acid (SUA), the overall risks of CHD and all-cause mortality increased by 20 and 9 %, respectively. According to the gender subgroup analyses, hyperuricemia increased the risk of CHD mortality in women (RR: 1.47; 95 % CI: 1.21–1.73) compared to men (RR: 1.10; 95 % CI: 1.00–1.19). The risk of all-cause mortality was greater in women. Hyperuricemia may modestly increase the risk of CHD and all-cause mortality. Future research is needed to determine whether urate–lowering therapy has beneficial effects for reducing CHD mortality.

23 August 2019 in Frontiers in Physiology
Verified
Journal Article
Open access
PDF file
XYXin Yin
Xin Yin
HXHuang Xin
Huang Xin
SMShuai Mao
Shuai Mao
GWGuangping Wu
Guangping Wu
LGLiheng Guo
Liheng Guo
Sepsis is a systemic inflammatory disease with infection, and autophagy has been shown to play an important role in sepsis. This review summarizes the main regulatory mechanisms of autophagy in sepsis and its latest research. Recent studies have shown that autophagy can regulate innate immune processes and acquired immune processes, and the regulation of autophagy in different immune cells is different. Mitophagy can select damaged mitochondria and remove it to deal with oxidative stress damage. The process of mitophagy is regulated by other factors. Non-coding RNA is also an important factor in the regulation of autophagy. In addition, more and more studies in recent years have shown that autophagy plays different roles in different organs. It tends to be protective in the lungs, heart, kidneys, and brain, and tends to be damaging in skeletal muscle. We also mentioned that some drugs can regulate autophagy. The process of modulating autophagy through drug intervention appears to be a new potential hope for the treatment of sepsis.

1 December 2016 in International Journal of Cardiology
Verified
Journal Article
Closed access
TZTian Zuo
Tian Zuo
LJLu Jiang
Lu Jiang
SMShuai Mao
Shuai Mao
XLXuehui Liu
Xuehui Liu
XYXin Yin
Xin Yin
LGLiheng Guo
Liheng Guo

8 December 2023 in Heart & Lung
Verified
Journal Article
Closed access
JZJin Zhu
Jin Zhu
YDYanyan Dong
Yanyan Dong
PLPengda Liao
Pengda Liao
XYXin Yin
Xin Yin
JHJianzhuo He
Jianzhuo He
LGLiheng Guo
Liheng Guo

24 October 2022 in Life Sciences
Verified
Journal Article
Closed access
YSYi Su
Yi Su
XYXin Yin
Xin Yin
XHXin Huang
Xin Huang
QGQianqian Guo
Qianqian Guo
MMMingyuan Ma
Mingyuan Ma
LGLiheng Guo
Liheng Guo

1 July 2015 in International Journal of Cardiology
Verified
Journal Article
Closed access
YRYi Ren
Yi Ren
RZRui-Xiang Zeng
Rui-Xiang Zeng
JLJian-Jun Li
Jian-Jun Li
LGLiheng Guo
Liheng Guo
DHDe-Ying He
De-Ying He
MZMinzhou Zhang
Minzhou Zhang